Lower nuclear expression of MT1 and MT2 was associated with well-differentiated grade, macro-vascular invasion, and poor long-term survival in patients with HCC (Park and Yu, 2013; Yang et al., 2018; Wang and Gribskov, 2019; Tamai et al., 2020). Here, MT1X is linked to hepatocellular carcinoma.